Diana S.M. Buist, PhD, MPH
Research interests and experience
- Cancer control: cancer screening and prevention; outreach and primary care prevention; comparative effectiveness; cost transparency; surveillance; secondary prevention; breast cancer treatment; breast cancer screening; outcomes following cancer diagnosis; cancer survivorship; provider variability in care
- Preventive medicine: cancer prevention and control; quality of care; preventive care; high-value care; consumer engagement in preventive medicine; systematic reviews
- Women's health: cancer prevention and control
- Aging & geriatrics: quality of care
What does optimal outreach, early detection, and preventive care for breast cancer look like? As a key member of two large research consortia focused on improving cancer screening and outcomes, Diana Buist is in a prime position to help answer this important question.
Dr. Buist is an epidemiologist and health services researcher whose work focuses primarily on early detection of breast cancer and reducing illness and death from breast cancer in populations. She is especially interested in translating research findings into clinically meaningful guidelines. Dr. Buist joined Group Health Research Institute (GHRI) in 1996 and within a few years became the Principal Investigator of the Group Health Breast Cancer Surveillance Project, one of seven sites participating in the National Cancer Institute's Breast Cancer Surveillance Consortium. She has also played a key role in several collaborative projects conducted by the HMO Cancer Research Network.
Her extensive experience working with these diverse data in longitudinal studies and randomized trials puts Dr. Buist in a unique position to examine cancer screening, care, and outcomes in health systems across the country. Because of her particular expertise in this area, she recently became a member of the Group Health-affiliated Evidence-based Practice Center—one of 11 centers funded by the Agency for Healthcare Research and Quality in 2012. Her role will include conducting systematic reviews for the U.S. Preventive Services Task Force.
Dr. Buist is an affiliate investigator at the Fred Hutchinson Cancer Research Center and an affiliate professor in the Departments of Epidemiology and Health Services at the University of Washington School of Public Health. She enjoys sharing her expertise by mentoring junior faculty and PhD and MPH candidates, co-directing the CRN Scholars Program, and teaching courses in clinical outcomes research internationally through the American Thoracic Society.
Houssami N, Abraham LA, Kerlikowske K, Buist DS, Irwig L, Lee J, Miglioretti DL. Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening. Cancer Epidemiol Biomarkers Prev. 2013 Mar 19 [Epub ahead of print]. PubMed
Hubbard RA, Zhu W, Horblyuk R, Karliner L, Sprague BL, Henderson L, Lee D, Onega T, Buist DS, Sweet A. Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography. Breast Cancer Res Treat. 2013 Mar 8. [Epub ahead of print].
Doubeni CA, Weinmann S, Adams K, Kamineni A, Buist DS, Ash AS, Rutter CM, Doria-Rose VP, Corley DA, Greenlee RT, Chubak J, Williams A, Kroll-Desrosiers AR, Johnson E, Webster J, Richert-Boe K, Levin TR, Fletcher RH, Weiss NS. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013;158(5 Pt 1):312-20. doi: 10.7326/0003-4819-158-5-201303050-00003. PubMed
Clough-Gorr KM, Thwin SS, Bosco JL, Silliman RA, Buist DS, Pawloski PA, Quinn VP, Prout MN. Incident malignancies among older long-term breast cancer survivors and an age-matched and site-matched nonbreast cancer comparison group over 10 years of follow-up. Cancer. 2012 Dec 26. doi: 10.1002/cncr.27914 [Epub ahead of print]. PubMed
Harvey JA, Gard CC, Miglioretti DL, Yankaskas BC, Kerlikowske K, Buist DS, Geller BA, Onega TL. Reported mammographic density: film-screen versus digital acquisition. Radiology. 2012 Dec 18 [Epub ahead of print]. PubMed
Kamineni A, Anderson ML, White E, Taplin SH, Porter P, Ballard-Barbash R, Malone K, Buist DS. Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population. Cancer Causes Control. 2012 Dec 7 [Epub ahead of print]. PubMed
Dallal CM, Brinton LA, Bauer DC, Buist DS, Cauley JA, Hue TF, LaCroix A, Tice JA, Chia VM, Falk R, Pfeiffer R, Pollak MN, Veenstra TD, Xu X, Lacey JV. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort. Endocr Relat Cancer. 2012 Dec 5 [Epub ahead of print]. PubMed
Hubbard RA, Zhu W, Onega TL, Fishman P, Henderson LM, Tosteson AN, Buist DS. Effects of digital mammography uptake on downstream breast-related care among older women. Med Care. 2012;50(12):1053-9. PubMed
Onega T, Smith M, Miglioretti DL, Carney PA, Geller BA, Kerlikowske K, Buist DS, Rosenberg RD, Smith RA, Sickles EA, Haneuse S, Anderson ML, Yankaskas B. Radiologist agreement for mammographic recall by case difficulty and finding type. J Am Coll Radiol. 2012;9(11):788-94. doi: 10.1016/j.jacr.2012.05.020. PubMed
Gao H, Buist DS, Lash TL, Bosco JL, Swihart B. Lasagna plots made in different (statistical) ovens. Epidemiology. 2012;23(6):934. doi: 10.1097/EDE.0b013e31826d08c7. PubMed
Aiello Bowles EJ, Boudreau DM, Chubak J, Yu O, Fujii M, Chestnut J, Buist DS. Patient reported discontinuation of endocrine therapy and related side effects among women with early stage breast cancer. J Oncol Prac. Nov 1, 2012: e149-57.
To view more publications, please see Dr. Buist's CV.